Design strategies and applications of biomaterials and devices for Hernia repair  by Kalaba, Surge et al.
lable at ScienceDirect
Bioactive Materials 1 (2016) 2e17Contents lists avaiBioactive Materials
journal homepage: http: / /www.keaipubl ishing.com/en/ journals /
bioact ive-mater ia ls /Design strategies and applications of biomaterials and devices for
Hernia repair
Surge Kalaba a, Ethan Gerhard a, Joshua S. Winder b, Eric M. Pauli b, Randy S. Haluck b,
Jian Yang a, *
a Department of Biomedical Engineering, Materials Research Institute, The Huck Institutes of the Life Sciences, The Pennsylvania State University, University
Park, PA 16802, USA
b Department of Surgery, College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USAa r t i c l e i n f o
Article history:
Received 8 March 2016
Received in revised form
10 May 2016
Accepted 20 May 2016
Available online 30 May 2016
Keywords:
Hernia repair
Hernia mesh
Hernia prosthesis
Hernia
Citric acid* Corresponding author. W340 Millennium Science
16802, USA.
E-mail address: jxy30@psu.edu (J. Yang).
Peer review under responsibility of KeAi Commu
http://dx.doi.org/10.1016/j.bioactmat.2016.05.002
2452-199X/© 2016 The Authors. Production and host
license (http://creativecommons.org/licenses/by-nc-na b s t r a c t
Hernia repair is one of the most commonly performed surgical procedures worldwide, with a multi-
billion dollar global market. Implant design remains a critical challenge for the successful repair and
prevention of recurrent hernias, and despite signiﬁcant progress, there is no ideal mesh for every surgery.
This review summarizes the evolution of prostheses design toward successful hernia repair beginning
with a description of the anatomy of the disease and the classiﬁcations of hernias. Next, the major
milestones in implant design are discussed. Commonly encountered complications and strategies to
minimize these adverse effects are described, followed by a thorough description of the implant char-
acteristics necessary for successful repair. Finally, available implants are categorized and their advantages
and limitations are elucidated, including non-absorbable and absorbable (synthetic and biologically
derived) prostheses, composite prostheses, and coated prostheses. This review not only summarizes the
state of the art in hernia repair, but also suggests future research directions toward improved hernia
repair utilizing novel materials and fabrication methods.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Contents
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1.1. The clinical relevance of Hernia repair
Hernia repair is among the most common surgical procedures
performed worldwide, with approximately 20 million procedures
performed annually [1]. Furthermore, the increasing prevalence of
abdominal surgeries as well as co-morbidities including obesity has
led to an increased risk of hernia development and recurrence [2].
Of the 4 million laparotomies conducted each year in the US alone,
up to 800,000 of these patients will later develop complications in
the form of incisional hernias [3]. Due to the overwhelming pres-
ence of this disease and related, post-operative conditions, the
Global Hernia Repair Devices and ConsumablesMarket is estimated
to reach $6.1 billion by the year 2020 [4].
1.2. Anatomy and physiology of the Hernia
Hernias can present in a variety of different ways depending on
their anatomical location as well as any predisposing factors. In
general terms, a hernia is classiﬁed as the protrusion of organs
through an opening in the cavity that is intended to contain them
[5]. The most common hernias are inguinal, ventral, incisional,
femoral, umbilical, hiatal, and epigastric [6]. Of the aforementioned,
inguinal hernias are the most frequent, accounting for nearly two-
thirds of all abdominal wall hernia procedures [7]. Inguinal herni-
ation consists of abdominal contents protruding through a defect in
the musculature of the groin [8]. The inguinal region is especially
vulnerable to herniation as a result of particular anatomical fea-
tures involving several layers of fascia and ligamentous tissue
coming together in a tight space. Outside of inguinal, almost all
other hernias of the abdominal wall can be categorized under
ventral hernias, with incisional and congenital being the two main
sub-classiﬁcations. Incisional herniation can occur as abdominal
contents protrude through defects created in the musculature from
previous surgical procedures or localized trauma [9]. On the other
hand, defects formed in the abdominal wall from birth that lead to
herniation can be classiﬁed as congenital.
At the level of the rectus superior to the umbilicus the abdom-
inal wall consists of multiple layers: skin, subcutaneous fat and
Scarpa’s fascia, anterior fascia (anterior rectus sheath), muscle
(rectus abdominis), posterior fascia (posterior rectus sheath),preperitoneal fat and peritoneum. The exact layers of the abdom-
inal wall differ depending on the exact location (medial to lateral, or
above and below the umbilicus) [10]. Collagenous connective tis-
sue, as is found in the dermis layer of the skin, also appears in
several layers throughout the abdominal wall, such as the subcu-
taneous fascia, transversalis fascia, and the pre-peritoneal layer
[11]. The structural integrity of the abdominal wall is provided
primarily by the integrated neuromuscular fascia of the transversus
abdominis, internal and external obliques, and the rectus abdom-
inis. These muscle groups impart the abdomen with sufﬁcient
mechanical strength and elasticity to withstand the pressures
generated within the cavity by the internal organs [11]. The peri-
toneum, which covers both the abdominal wall and the internal
organs contained within, enables the organs to move within the
abdomen without detaching [11]. A detailed rendering of the
abdominal wall and its components is shown below (Fig. 1).
Abdominal hernias develop due to areas of structurally
compromised tissues within the abdominal wall. In most cases,
hernias occur when damage is sustained to the inner four layers of
the abdominal wall, although this is location-dependent (for
instance, in the midline a hernia develops when only the midline
fascia, or linea alba, is damaged). Excessive damage and loss of
musculature within the wall is replaced with scar and connective
tissues, which are unable to withstand the pressures exertedwithin
the cavity [11]. Normal everyday actions including laughing, lifting,
coughing and standing can signiﬁcantly increase the intra-
abdominal pressure exerted on the abdominal wall. In patients
with compromised abdominal wall structure, a substantial increase
in intra-abdominal pressure is enough to tear or bulge the
abdomen, resulting in a hernia [11]. Additionally, herniation can
result from several pathological conditions, such as congenital birth
defects of the abdominal wall as well as excessively high intra-
abdominal pressure as a result of obesity, ascites, straining due to
benign prostatic hypertrophy or constipation, pregnancy and pul-
monary diseases in conjunction with chronic coughing [12].
2. The evolution of Hernia repair
2.1. Suture repair
As early as the 1800s, the adverse effects inguinal hernias pre-
sented to their patients were recognized and understood. It became
Fig. 1. Detailed rendering of the human abdominal wall with subsequent components.
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need for an artiﬁcial prosthetic capable of replicating the “density
and toughness of fascia and tendon” was necessary in order to
effectively cure hernia symptoms [13]. Prior to the introduction of
novel biomaterials, suture repair, comprising multiple techniques
such as Bassini’s for inguinal hernias, was the most common
method of abdominal hernia repair.
Bassini’s technique utilizedmusculo-aponeurotic repair in order
to close abdominal wall defects using sutures under tension [14].
Additional, commonly used suture techniques include simple
fascial closure, Mayo with overlap of fascial edges, internal reten-
tion sutures, “keel” procedure and the Nuttall procedure [15].
Bassini began his work with silk sutures, transitioning to silver in
order to introduce bactericidal properties [16]. Although suture
repair can be successful, these techniques suffer from high reoc-
currence rates [14].
2.2. Introduction of Hernia meshes
According to George and Ellis, suture repair techniques are
fundamentally ﬂawed in that they subject afﬂicted tissues to un-
needed tension, resulting in ischemia, suture cut-out and overall
repair failure [17]. Metal sutures began to be reinforced with silver
coils by Phelps and later with stainless steel meshes by Babcock.
Stainless steel remained themost effective metal; however, its rigid
material properties resulted in patient abdominal stiffness,
discomfort, sinus formation and ﬁbrotic response [16].
2.3. Mersilene (Ethicon)
In response to the biologically unacceptable performance of
metal prosthetics, plastics became the main area of focus for
abdominal wall repair in the late 1950s [16]. Dacron, marketed by
Ethicon under the trade name Mersilene, became the ﬁrst
nonmetallic, polyester material to be used for abdominal wall
prosthesis by Wolstenholme. Stoppa and colleagues utilized large
Dacron prostheses, six to ten times larger than the hernia defect, in
the pre-peritoneal space to repair abdominal wall defects without
the use of sutures. Due to the signiﬁcant overlap of the Dacron
fabric, this method relied on the intra-abdominal pressure and the
subsequent tissue in-growth for ﬁxation of the prosthesis [18].
Although Dacron polyester meshes were the ﬁrst non-metallic
prostheses to be used for abdominal hernia repair, a transition to
polypropylene based materials occurred as they were believed to
be more resistant to infection and tissue adhesion [16].2.4. Marlex (Bard)
In 1958, Francis Usher introduced the world’s ﬁrst polyethylene
mesh [13]. The Marlex mesh was comprised of monoﬁlament high
density polyethylene which was woven using hot-melt extrusion
[19]. Usher was particularly interested in Marlex because it was
strong, inert, non-wettable, and it resisted fragmentation when
manipulated. Furthermore, the Marlex mesh provided a pliable
alternative to previous, rigid metal prostheses, which lead to
reduced patient discomfort and pain [18]. Usher optimized mesh
design parameters such as thickness, porosity, stretch-ability and
tensile strength and reported that 20% of surgeons were using this
prosthesis for abdominal wall repair. In 1962, Usher introduced an
improved version of the Marlex mesh marketed by C.R Bard made
from polypropylene [16]. The mesh improvements unveiled by
Usher and colleagues provided surgeons with substantially
expanded treatment options for tension-free abdominal wall hernia
repair [20]. Plastic meshes made it possible for surgeons to repair
hernias by bridging tissue gaps rather than subjecting them to high
tension suture closures, resulting in adecrease in reoccurrences [18].
2.5. ePTFE
In 1963, expanded polytetraﬂuoroethylene (ePTFE), was
discovered by Sumitoma Electric Industries of Japan. A processed
version of PTFE, commonly referred to as Teﬂon, ePTFE differed in
that it contained a highly uniform, continuous ﬁbrous porous
structure with greatly enhanced mechanical strength. W.L Gore
reﬁned this process and in 1983 developed the Gore-Tex Soft Tissue
Patch (STP), which was used clinically as a hernia repair prosthesis
[18]. The Gore-Tex STP patch was stronger, with suture retention
strength equivalent to Marlex (Bard), Prolene (Ethicon) and Mer-
silene (Ethicon) meshes [21]. Due to the inert nature of the mate-
rial, The Gore-Tex soft tissue patch became especially useful in
intra-peritoneal hernia mesh placement. In contrast to poly-
propylene, ePTFE meshes placed intra-abdominally produce less
inﬂammatory response and form fewer adhesions to the internal
viscera [16]. Koehler and colleagues performed intraabdominal
hernia repairs using a ePTFE Dual Mesh (Gore) and found that of 65
patients, 59 (91%) presented no or very thin avascular visceral ad-
hesions 14 days after implantation [22].
3. Prostheses for Hernia repair: necessity and complications
Surgical hernia repair studies performed on large groups of
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reduction in recurrence risk for ventral hernias [23]. With regards to
incisional hernias, which occur due to compromised musculature
resulting from previous abdominal surgeries, the use of mesh pros-
thetics for repair can decrease the risk of reoccurrence 24 times [24].
The beneﬁts mesh prostheses present to abdominal wall hernia
repair are overwhelming. Surgeons continue to search for ideal ma-
terials andmethods that can further improve patient outcomes [25].
The goal of surgical mesh prostheses for hernia repair is to
fortify and replace localized tissue defects in an effort to stabilize
the abdominal wall for long term relief of symptoms [26]. Since the
introduction of mesh prosthetics in the 1950s, several variations
and adjustments in design have been presented in hopes of
developing an “ideal” prosthetic. In reality, the use of a single mesh
design capable of functioning effectively in all scenarios is unreal-
istic. Surgical repair requirements vary depending on the type of
hernia along with several other parameters such as defect size and
applied surgical technique [26]. In general terms, mesh prostheses
should possess good handling properties, induce a desired host
response, integrate with surrounding tissues and demonstrate
sufﬁcient mechanical properties for abdominal wall stabilization
[27,28]. Moreover, when examining materials and prostheses for
abdominal wall repair, surgeons must take into account several
additional physiological considerations to better understand the
suitability of the implant.
3.1. Cyto-compatibility/foreign body response
According to Williams, “ the single most important factor that
distinguishes a biomaterial from any other material is its ability to
exist in contact with tissues of the human body without causing an
unacceptable degree of harm to that body” [29]. Materials used for
abdominal wall repair must remain biologically inert and resist
rejection [30]. Biomaterials used for mesh prostheses can prompt
adverse inﬂammatory foreign body responses (FBR) including
ﬁbrosis, calciﬁcation, thrombosis, infection, as well as granuloma,
ﬁstula and seroma formation [31,32]. Commonly used mesh pros-
thetic materials, such as polypropylene (PP), polyethylene-
terephthalate (PET), and ePTFE, produce varying FBRs due to
differing physiochemical properties on the surface of the implant
[31]. Alternatively, biologically derived meshes are capable of dis-
playing diminished FBR, particularly in the long term, due to their
improved integrationwith neo-tissue and the presence of bioactive
signals and growth factors within the bio-derived materials [33].
Moreover, researchers have deduced relationships between pros-
thesis design and host response that may act to counter some of the
adverse reactions produced from the materials inherent chemical
properties. For example, larger mesh pore sizes have been shown to
yield signiﬁcantly less FBR and ﬁbrosis of localized tissues when
compared to meshes with small pore sizes [34]. Recently, there has
been substantial focus on the development of technical improve-
ments to mesh design in order to improve local integration of
prostheses by host tissues [24].
3.2. Collagen composition
Mesh prostheses implanted in the body canmodify the naturally
occurring collagen compositions found in the abdominal wall. The
normal conversion of Type I collagen from immature Type III
collagen is delayed in the presence of foreign bodies such as sur-
gical meshes. The increase in Type III collagen could alter the
mechanisms responsible for the deposition of Type I collagen,
resulting in localized tissues with signiﬁcantly decreased me-
chanical stability [35,36]. A reduction in Type I to Type III collagen
ratio also has considerable implications for the recurrence ofhernias [37]. Junge and colleagues found that the Type I/III collagen
ratio in patients requiring ex-plantation of prosthesis due to
recurrence was signiﬁcantly lower (1.3 ± 0.7) compared to those
experiencing chronic pain (3.4 ± 1.2) or infection (2.9 ± 1.6). These
results indicate the dependence of abdominal wall mechanical
stability on collagen composition [37].
3.3. Resistance to adhesion/ﬁstula formation
An important property of mesh prosthetics is their ability to
inﬁltrate host abdominal wall tissues in order to create a strong and
secure repair. Unfortunately, due to the porous nature of most
prosthetic meshes, interaction with undesired tissues is possible as
can be seen with the adherence of meshes to the bowel [13]. Ideal
mesh based prostheses for abdominal wall hernias will provide
fascial defect repair capabilities, integrate into surrounding tissues
by allowing tissue in-growth, and inhibit the formation of
abdominal tissue adhesions to the mesh surface [38]. Abdominal
adhesions are estimated to occur in 90% of all abdominal wall repair
procedures and involve irregular ﬁbrous strands that attach be-
tween tissues and organs within the abdominal cavity and the
prosthesis [39]. The adhesions formed within the abdominal cavity
progress to the formation of collagen dense extra-cellular matrix
(ECM) which effectively closes the gap between internal viscera
and prosthetic [33]. The occurrence of adhesions in hernia repair is
predicated around the introduction of foreign bodies to injured
peritoneal surfaces within the abdominal cavity [8,40,41]. The
formation of adhesion sites within the abdominal cavity can cause
chronic abdominal pain, bowel obstructions and perforations,
enterocutaneous ﬁstulae, as well as migration of prosthesis, and is
responsible for 15e20% of female infertility cases
[12,28,33,38,42e44]. Design and construction parameters of
biomaterial prostheses can inﬂuence the development of adhesions
as well as the production of neoperitoneum, which is formed be-
tween the material and visceral peritoneum [28].
3.4. Resistance to infection
The implantation of prosthetics within an abdominal wound can
lead to the appropriation of necrotic debris and slime-producing
bacteria resulting in surgical infection [27]. The use of mesh pros-
thesis in open ventral hernia repair can result in infection rates as
high as 18%. Patients presenting with abdominal wall infections are
generally treated by removing the prosthetic, requiring the patient
to undergo further surgery [45]. Infections occur as a result of the
inﬁltration and proliferation of bacteria within the pores of the
prosthetic [13]. Such infections are considered to be the main cause
of incisional hernia formation in patients that have undergone
previous abdominal surgery [46]. The design of a mesh plays a
critical role in the propagation of wound infections in patients
requiring the use of prostheses for abdominal wall repair [30].
Macroporous meshes containing pore sizes greater than 75 mm
have been shown to produce less infection when compared to
microporous counterparts. Multiﬁlament meshes designed with
pores smaller than 10 mm allow for the inﬁltration of bacteria while
preventing macrophages from entering to combat the infection.
3.5. Seroma/hematoma formation
A common complication resulting from the use of mesh pros-
theses for abdominal wall hernia repair is the formation of a seroma
or hematoma. Seromas and hematomas develop as a result of the
host inﬂammatory response to a foreign body and are deﬁned by
ﬂuid build-ups in the subcutaneous space containing serous ﬂuid or
blood, respectively [13,47]. The production of ﬂuid pockets around
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sue, inhibiting the host tissues’ ability to inﬁltrate and secure the
prosthesis successfully. Meshes designed to facilitate rapid ﬁbri-
nous ﬁxation to host tissues are able to minimize dead space be-
tween prosthesis and native tissues, thereby minimizing the
formation of seromas [13,30].
4. Prostheses for hernia repair: ideal material and design
properties
The design and construction parameters of surgical meshes can
greatly alter the behavior of the prosthetic itself and should be fully
understood before making appropriate selections for repair.
Although several design parameters exist, most commercially
availablemeshes can be generally categorized according to ﬁlament
constitution (mono vs. multiﬁlament), pore size (macro vs micro),
andweight (light vs. heavy). Although one designmay present clear
advantages over another, it is difﬁcult to pin-point a single product
that contains all of the properties of an ideal mesh [48]. For
example, a microporous mesh may provide better resistance to
adhesions, but would fail to prevent infections as effectively as
macroporousmeshes [34]. No single ideal mesh exists, as is evident
from the large variety of mesh materials and designs in today’s
market [35]. In order for surgeons to provide the best possible
outcomes for their patients, they must ﬁrst understand the
biomechanical and compositional properties of the mesh designs
available to choose from.
4.1. Pore size
The porosity of a prosthesis refers to the ratio of open to solid
space with respect to volume, area, or weight. The porosity of an
artiﬁcial prosthesis plays an extremely important role in the overall
performance of the implant as it is directly proportional to the
degree of host tissue incorporation [49]. Amid classiﬁed the most
frequently used materials for hernia surgery into four different
types based on their pore sizes (Table 1) [13]. Type I meshes, con-
taining pores larger than 75 mm, allow for more profound inﬁltra-
tion of macrophages, blood vessels, and collagen. Additionally, Type
I meshes permit increased soft tissue in-growth and are more
ﬂexible than microporous meshes due to the inhibition of granu-
loma bridging [50]. Although the formation of granulomas is ex-
pected around the ﬁbers of a mesh, bridging occurs when
granulomas become conﬂuent with one another and encapsulate
the entire mesh [35,51]. Studies suggest that meshes containing
pores larger than 1 mm are able to promote adequate wound
healing while reducing the presence of dense scar tissue formed
from granuloma bridging [24,52]. Furthermore, as a result of host
penetration, meshes constructed using large pores appear to pro-
mote increased vascularization and collagen deposition [53]. In
concurrencewith these ﬁndings, studies have shown that the use of
large pore meshes in non-contaminated environments can also
counteract the presence of infections and seromas [54,55]. Along
with erosion and migration into the GI tract, a fundamental
disadvantage associated with the use of macroporous meshes is the
risk of adhesion to internal viscera [13,56e58].
Recently, some manufacturers have begun developingTable 1
Categories of prosthetic pore size [27].
Very Large pore >2,000 mm
Large Pore 1000e2000 mm
Medium Pore 600e1000 mm
Small Pore 100e600 mm
Microporous (Foil) <100 mmcomposite meshes, which combine materials in order to utilize the
advantages of each. Composite meshes generally require implan-
tation in a particular orientation in order to utilize the full beneﬁt of
the design [59]. A composite mesh designed with ideal porosities
for both the viscera and parietal regions would contain a macro-
porous surface exposed to the parietal side to allow tissue in-
growth, and a microporous surface in contact with the internal
organs to prevent the formation of adhesions [56,59].
4.2. Weight
A previous lack of understanding regarding the biomechanical
nature of intraabdominal forces led to a generation of mesh pros-
thetics which were over-engineered and contained too much
foreignmaterial. These “heavyweight”meshes led to chronic pain, a
loss of abdominal wall compliance and mesh shrinkage. More
recently, improved mesh prosthetics have been designed contain-
ing signiﬁcantly less material while still providing sufﬁcient me-
chanical strength to repair abdominal wall defects [60,61]. In
today’s market, synthetic meshes are categorized as either being
heavyweight, lightweight or medium weight (Table 2) [59]. These
terms can sometimes be difﬁcult to interpret due to vague de-
scriptions and a lack of consensus provided in literature [26].
Fundamentally, the three groups are different in terms of several
physical properties such as thickness, weight, ultimate tensile
strength and modulus of elasticity [60].
Lightweight meshes generally contain larger pore sizes
(>1 mm), thinner ﬁlaments, improved elasticity (25e35%), smaller
surface areas, a decrease in overall weight/foreign material and
shrink less in physiological conditions compared to their heavy-
weight counterparts [26,31,51]. Such properties allow lightweight
meshes to inhibit the formation of dense scar tissue while still
maintaining sufﬁcient mechanical strength. As a result, the
repaired abdominal wall is able to maintain its ﬂexibility and
functions as a dynamic system in spite of the foreign prosthesis
[62].
In contrast, heavyweight prosthetics have thick polymer ﬁbers,
small pores, high tensile strength and increased surface area [31].
Consequently, heavyweight meshes are associated with intensiﬁed
adverse effects including profound foreign body response, chronic
pain, ﬁbrosis, as well as the formation of adhesions, ﬁstulae and
scar tissue [31,51,63]. In summary, the use of lightweight pros-
thetics for hernia repair appears to be far more beneﬁcial in
reducing long-term complications such as chronic pain, inﬂam-
matory reaction and ﬁbrous formation [64]. These results suggest
that the biological response associated with lightweight meshes is
signiﬁcantly more favorable compared to heavyweight meshes
[65].
4.3. Filament structure
Prosthetic meshes used for hernia repair are developed from
various polymers in either a mono or multi-ﬁlament extrusion [50].
An ideal mesh design would include the following properties:
resistance to infection, molecular permeability, pliability and me-
chanical functionality. Monoﬁlament polypropylene meshes
adequately satisfy the aforementioned requirements and are theTable 2
Categories of prosthetic density [27].
Heavyweight >90 g/m2
Medium weight 50e90 g/m2
Lightweight 35e50 g/m2
Ultra-lightweight <35 g/m2
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Multiﬁlament meshes, which consist of several braided ﬁbers, are
associated with an increased risk of infection, granuloma formation
and sinus tract formation, and promote increased inﬂammatory
response. The risk of infection is a prominent phenomenon in
multiﬁlament meshes as a result of small (~10 mm) interstices
produced in-between braided ﬁbers. Interestingly, the small gaps
are large enough for the inﬁltration of bacteria, but too small for the
penetration of neutrophil and macrophage cells which are
responsible for eliminating the bacteria [30,32,66,67]. Although
infection is theoretically possible with any mesh, infections
occurring from monoﬁlament meshes generally do not require
immediate ex-plantations, as is the case with multiﬁlament pros-
thetics. Furthermore, studies performed by Klinge and colleagues
demonstrated a signiﬁcant increase in the adherence of Staphylo-
coccus aureus bacteria to multiﬁlament meshes for all concentra-
tions of bacteria when compared tomonoﬁlament equivalents [68].
Although multiﬁlament meshes have been reported to be more
pliable than lightweight monoﬁlament prosthetics, manufactures
are developing a new generation of meshes containing partially
absorbable ﬁlaments which provide additional handling properties
[48,61]. An important property of mesh fabrics is the method in
which they are processed. Knitted meshes are commonly more
porous and ﬂexible; however, they lack the mechanical strength of
woven meshes due to a decrease in ﬁlament density [69]. Addi-
tionally, the mechanical properties of knitted and woven meshes
can differ depending on the spatial orientation, a concept that will
be discussed in the mechanical properties section.
4.4. Mechanical strength/elasticity
The human abdominal wall is composed of a laminar structure,
containing several sheet-likemuscles and tendinous ﬁbers oriented
in various directions [70]. The lateral forces produced from
contraction of the oblique and transverse muscles are signiﬁcantly
greater than the stresses generated in longitudinal directions. Thus,
the abdominal wall appears to be inherently ridged in the hori-
zontal direction while remaining naturally elastic in the vertical
[70e72]. The proper repair of abdominal wall hernias is dependent
upon the design of a prosthetic capable of mimicking the biome-
chanical nature of the native tissues. Studies conducted by Cobb
and associates suggest the highest intraabdominal pressure in
humans is generated during coughing and jumping. These values
correspond to a peak intraabdominal pressure of 171 mmHg [73].
These values can be converted to mean tensile strength using
Laplace’s Law, which relates tension, diameter, pressure and wall
thickness. Therefore, it can be concluded that the maximum
theoretical tensile strength per unit width that prosthetic meshes
must withstand for successful repair of large and small hernias is
32 N/cm and 16 N/cm, respectively [31,35,72,74e76]. First genera-
tion heavyweight meshes were crudely over-engineered, contain-
ing too much foreign material providing unnecessarily large tensile
strengths of nearly 100 N/cm [35,51]. In today’s market, all available
mesh prosthetics, including lightweight meshes, possess the
structural integrity to meet the mechanical needs for physiological
repair [31,62,75e77].
Along with possessing required mechanical strength to provide
sufﬁcient repair, prosthetic meshes should be capable of mimicking
the natural distensibility of the abdominal wall. Junge and associ-
ates determined the mean vertical elasticity of the abdominal wall
at 16 N was 23 ± 7% for males (15%e37% range), and 32 ± 17% for
females (12%e69% range). The elasticities in the horizontal direc-
tion at 16 N were, 15 ± 5% for the males (9%e23% range), and
17 ± 5% for females (7%e24% range). In general, mean elasticities
were determined to be between 11% and 32% in all directions(horizontal, vertical, and oblique) at a force of 16 N [78]. Heavy
meshes used for hernia repair that do not account for the natural
pliability of surrounding tissues will result in severe restriction of
the mobility of the abdominal wall which can lead to discomfort
and pain [78e81]. Heavyweight meshes generally present elastic-
ities in the range of 4%e16%, while lightweight counterparts can be
as high as 20%e35% [31], [78]. Current and next generation mesh
design concepts are transitioning towards lighter and more elastic
prostheses, which are capable of mimicking the physiological
environment. Understanding the design properties and character-
istics of modern hernia meshes can allow surgeons to better predict
their functions in vivo.5. Biomaterials for hernia meshes
Over the last several decades, the use of mesh prosthetics has
become an ordinary practice in most countries and is the preferred
course of treatment for hernia repair. Since the original metal
prosthesis introduced in the early 1900s by Witzel and Goepel,
progressive development of new materials and methods for hernia
repair has occurred [16]. Although the use of mesh prostheses has
become the gold standard due to a prominent decrease in reoc-
currence rates when compared to primary suture repair, the
potentially problematic physiological interactions present between
prosthetic and host tissue cannot be ignored [82]. The introduction
of a non-native prosthetic material into the human body is quickly
followed by a systematic foreign body response activated by the
host’s immune system. Consequently, the resultant FBR associated
with hernia repair can manifest into severe problems such as
seroma formation, mesh shrinkage or encapsulation, tissue degra-
dation and chronic pain [33]. At present, the most common treat-
ment options for hernia repair involve the use of prosthetic
biomaterials (absorbable, non-absorbable, composite, coated,
impregnated), xenografts and allografts [10]. This section aims to
outline and categorize the currently available options for prosthe-
ses that physicians have at their disposal.5.1. Non-absorbable prostheses
Commonly used synthetic non-absorbable biomaterials such as
polypropylene (PP) (Table 3), polyethylene terephthalate (PET or
polyester) (Table 4), and expanded poly-tetraﬂuoroethylene
(ePTFE) (Table 5) are the fundamental pillars of most hernia pros-
theses used today. Since its inception in the early 1960s, poly-
propylene has remained the most commonly used synthetic
biomaterial for hernia repair [51]. Although all of the aforemen-
tioned materials are readily available in a clinical setting as a result
of their alleged biocompatibility and inertness, some studies sug-
gest these materials may activate certain histopathological pro-
cesses and immune reactions upon implantation [33].
A key advantage in using polypropylene meshes for hernia
repair is the ability of host tissue to inﬁltrate and integrate into the
prosthesis. However, PP’s propensity to form adhesions with
visceral organs and tissues remains one of its major weaknesses. On
the other hand, ePTFE meshes are advantageous in preventing
visceral adhesions, though they lack the ability to promote sufﬁ-
cient parietal host tissue in-growth [83]. Lastly, PET meshes are
valuable due to their superior histological properties, strong tissue
in-growth and conformity to the abdominal wall [48].
PET meshes appear to be more cytocompatible than PP, pre-
senting with a less profound foreign body and inﬂammatory re-
action [31,32]. However, long term stability and susceptibility to
infection remain pressing concerns regarding the use of pure
polyester meshes as hernia repair prostheses [48].
Table 4
Polyethylene terephthalate (PET) Mesh.
Product name® Pore size (mm) Weight(g/m2) Filament structure
Mersilene (Ethicon) 1 [156] 33e40 [35,156] Multiﬁlament [31]
Parietex (Covidien) [147] 1.0e1.6 38 Multiﬁlament
Table 5
ePTFE and PTFE meshes.
Product name® Pore size (mm) Weight(g/m2) Filament structure
DualMesh (Gore) 0.003/0.022 mm [157] 320 [158] Foil [31]
Soft Tissue Patch (Gore) 1.3 [159] Heavyweight [35] Nonwoven [159]
MycroMesh (Gore) 0.025/0.3 [159] Heavyweight [35] 2 mm perforations [160]
Table 3
Common polypropylene Hernia meshes.
Product name® Pore size (mm) Weight (g/m2) Filament structure
Prolene (Ethicon) 0.8e1.6 [35,146] 105e108 [61,146] Monoﬁlament [31]
Parietene (Covidien) 1.0e1.6 [147] 78 [147] Monoﬁlament [72]
Parietene Light (Sofradim) 1.5 [148]e1.7 [149] 38 [149] Monoﬁlament [150]
Serapren (Serag-Wiessner) 0.08e0.1 [146] 116 [146] Multiﬁlament þ Monoﬁlament [146,151]
Surgipro (United States Surgical) 0.8 [35] 110 [61] Monoﬁlament þ multiﬁlament [66,72]
Marlex (Bard) 0.46 [52] 95 [61] Monoﬁlament [31]
BardSoft (Bard) 2.5 [149] 44 [149] Monoﬁlament [152]
Prolite (Atrium) 0.8 [153] 85 [153] 90 [61] Monoﬁlament [61]
Atrium (Atrium) 0.8 [154] 92 [154] Monoﬁlament [31]
Trelex (Meadox) 0.35e0.6 [153] 95 [153] Monoﬁlament [51]
Optilene (B-Braun) 1.0 [149] 36 e48 [149,155] Monoﬁlament [150]
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Fully absorbable meshes were designed to create prosthetic
devices that were capable of serving their intended function while
minimizing the amount of foreign material left over for the body to
contend with. In principle, these designs are capable of alleviating
the intense foreign body and immune response that is seen with
non-absorbable meshes [33]. The most commonly used absorbable
meshes are reviewed below (Table 6). Overall, the use of absorbable
meshes for hernia repair presents several advantages over con-
ventional, permanent prostheses. Most notably, permanent meshes
can act as vessels for the proliferation of bacteria, which increases
the risk of infections post implantation [13]. As a result, non-
absorbable meshes may be problematic in pre-contaminated en-
vironments [84]. Furthermore, studies suggest that the use of non-
absorbable meshes in children can hamper normal tissue growth
[85]. Finally, non-absorbable meshes are associated with increased
risk of ﬁstula formation, chronic pain and a general restriction of
physical movement [85,86].5.3. Biologically derived prostheses
Biologically derived mesh prostheses have been largely devel-
oped for open abdomen conditions presenting contamination or a
high risk of contamination [51]. Fundamentally, biological pros-
theses are extracellular matrices obtained from decellularized
living tissues that are designed to function as active scaffolds,
allowing native cells to populate the mesh in order to activate the
remodeling process [27,33]. Unlike synthetic prosthetic meshes,
biological materials used for hernia repair can become highly vas-
cularized over time. As a result, these materials promote host
collagen deposition and tissue in growth as they slowly degrade.
The end result is the formation of functional neo-tissue, which
provides strength and integrity to localized defect sites [33,48].
Biological prostheses can be classiﬁed according to their origin:
xenogenic (animal) (Table 7) or allogenic (cadaveric acellular
dermal matrices) (Table 8) [33].In addition to the matrices derived from acellular dermal and
small intestine submucosa tissues, researchers are also developing
Acellular Bladder Matrices (ABM). Eberli and associates are devel-
oping collagen based layered biomaterials from porcine bladder
submucosa, known as the lamina propria. Both single and
quadruple layer ABM have demonstrated exceptional biocompati-
bility with marked inﬂux of ﬁbroblast and lymphocyte cells over
time [87]. Researchers have also fabricated mesh prostheses using
silk proteins isolated from both worms and spiders. Silk derived
fromworms has been shown to produce various immune responses
and is considered to be less biocompatible than spider silk due to a
lack of natural lubricant coatings [88,89].
Overall, biologically derived prostheses for hernia repair are
advantageous in that they contain a dense network of collagen as
well as several bioactive signals and growth factors. These cues,
which include, proteoglycan, elastin and hyaluronan, along with
the physical construct of the matrix itself can promote impressive
tissue remodeling and wound healing in hernia patients [33].6. Composite & combination prostheses
The long-term mechanical stability concerns associated with
fully absorbable meshes have prompted a new generation of
composite prostheses to emerge, combining non-absorbable ma-
terials with absorbable ones. As a result, composite meshes
demonstrate the mechanical handling properties of conventional
permanent polymers such as PP and PET, while reducing the overall
meshweight through the use of absorbable ﬁbers integratedwithin
the mesh construct [27].
Combination meshes utilize the advantages of multiple mate-
rials to create an orientationally dependent prosthesis [51]. Similar
to composite meshes, the goal of combination meshes is to create
prostheses capable of being successfully implanted laparoscopi-
cally into the intraperitoneal space. In order to promote tissue
ingrowth while simultaneously attenuating intestinal adhesion/
ﬁstula formation, combination meshes are constructed with
different surface materials for the parietal (abdominal wall) and
Table 6
Common absorbable meshes.
Product Material Design Pros Cons
Dexon (Davis & Geck)
Saﬁl (B-Braun)
Poly (glycolic) acid
(PGA)
Multiﬁlament [161]  Anti-bacterial degradation
productions allow for use in
contaminated environments [84]
 Induces minimal inﬂammatory
response with moderate ﬁbrosis
[161]
 Resistance to adhesion formation
[48]
 Rapid mesh degradation resulting in
mechanically unstable collagen
formation leading to high
reoccurrence rates [33,48,84]
Vicryl (Ethicon) Polyglactin 910 (92%
glycolide, 8% lactide
[33]
Multiﬁlament and
woven [162]
0.5 mm pore size and
50 g/m2 weight [85]
 Improved mechanical stability
compared to purely PGA meshes
with introduction of PLA [33]
 Able to maintain mechanical stability
of non-absorbable prosthesis up to 3
weeks post implantation [163]
 Although improved from PGA,
mechanical tensile strength was not
sufﬁcient over prolonged time period
[163]
 Stimulate inﬂammatory response
and formation of scar tissue [85]
 Loss of mechanical stability after 6
months in saline [85]
Polylactide Mesh(Ethicon)
[85]
Polylactide (95%
Lactide, 5% glycolide
Multiﬁlament with
pores 0.2e1.4 mm in
size and weight of 50 g/
m2
 Further improved mechanical
properties with 50% retention of
tensile strength after 9 months
(functional assessment)
 Improved seam tearing retention
over Polyglactin
 Decreased rate of seroma compared
to Polyglactin
 Decreased connective tissue
formation inﬂammation response
compared to Polyglactin.
 Activate the formation of foreign
body granuloma and giant cells
 Although mechanical stability is
improved, long term studies testing
Polylactide meshes ability to prevent
incisional herniation and adhesion
formation.
TIGR (Novus Scientiﬁc)
[164,165]
Fast degrading: PLGA-
PTMC poly
(trimethylene
carbonate).
Slow Degrading: PLA-
PTMC
Macroporous,
multiﬁlament mesh
knitted 2 resorbable
ﬁlaments, a slow and
fast degrading ﬁber
 Long term (6 month) resorbable
nature preserves mechanical
function better than competitor
resorbable meshes made from PGA,
PLA or polyglactin.
 Collagen deposition more similar to
native connective tissue
 Enhanced tissue integration
 After degradation, mesh is replaced
with newly formed collagen matrix,
with increased ratio of type I/III
collagen.
 Studies were not conducted on
patients with collagen deﬁciencies
 Potential mechanical load bearing
issues after mesh has fully degraded
are present
GORE BIOA
(Gore)[33,166,167]
PGA - PTMC Electrospun
membranes of PGA-
PTMC copolymer
 Interconnected ﬁbers created from
electrospinning optimize tissue in-
growth.
 Able to resist infection
 Suggested reports indicate the BIOA
may be beneﬁcial to use in
contaminated environments
 Long term mechanical strength is
questioned due to degradation of
materials.
Phasix (Bard)
[168]
Poly(4-
hydroxybutyrate)
(P4HB)
Knitted Monoﬁlament
Weight: 182 g/m2
Pore Size: 0.0004 in2
 Mesh provides short term support
that is comparable to permanent
meshes.
 Provides absorbable scaffold allowing
abdominal wall to remodel and
regenerate overtime.
 Resistant to infection due to
monoﬁlament mesh design.
 Mesh is made from natural polymer
unlike other absorbable meshes.
Metabolic byproducts of degradation
are far less acidic than glycolic and
lactic acid
 Long degradation time (>72 weeks in
male Yucatan swine).
 Typical issues of bulk erosion
materials for long-term implantation.
 Limited information regarding the
long-term in vivo host responses.
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commonly used composite and combination meshes (Table 9).
7. Coated prostheses
In an effort to further mitigate the foreign body response seen
with most modern prostheses, manufacturers have begun func-
tionalizing the surfaces of common mesh prosthetics with biolog-
ical, chemical, and physical treatments [33]. Due to increasing
demand for intraperitoneal mesh placement, coated meshes have
been modiﬁed accordingly in order promote adequate tissueintegration, while minimizing the formation of adhesions. The
most commonly usedmesh coatings are reviewed below (Table 10).
In addition to the modiﬁcations outlined above, meshes are
being coated with various alternative substrates in order to
improve their bio-functionality. Wolf and Faulk demonstrated an
attenuated foreign body and inﬂammatory response in poly-
propylene meshes coated with extra-cellular matrix (ECM) hydro-
gels derived from porcine dermis or urinary bladder. The studies
conducted showed that the use of ECM coated meshes resulted in
an increase in the M2/M1 macrophage population ratio, which is
responsible for tissue remodeling rather than inﬂammation [90,91].
Table 7
Common xenogenic meshes.
Meshes constructed from small intestine submucosa (SIS)
Product Design Comments
Surgisis (Cook
Surgical)
[163,169]
Constructed using four layers of acellular SIS tissue. Mostly acceular, however
occasional ﬁbroblast and endothelial cells may remain within construct
Supports new vessel growth and acts as scaffold for remodeling of
localized tissues. May decrease risk of infection in contaminated
environments
Fortagen
(Organogenesis)
[170]
Matrix is crosslinked with 1-ethyl-3 (3-dimethylaminopropyl) carbodiimide
hydrochloride (EDC) (rectocele repair)
Crosslinking may disrupt tissue integration and remodeling. Material
may be perceived as foreign due to crosslinking.
Meshes Derived from Acellular Porcine Derma Tissue
Product Design Comments
Permacol
(Covidien)
Chemically crosslinking using hexamethylene diisocyanate (HMDI) to delay
degradation of collagen ﬁbers and improve prosthesis stability [33,171]
Low antigenicity, little inﬂammatory reaction, resistant to adhesion
formation. Promising integration and neovascularization with host
tissues [172]
Collamend (Davol) Chemically crosslinking using carbodiimide hydrochloride (EDAC) to delay
degradation of collagen ﬁbers and improve prosthesis stability [33,173]
Has been shown to produce less mechanical failure and infection
compared to Permacol. Collamend and Permacol both produced poor
tissue integration due to the crosslinked components of their design
[173]
Strattice (Life Cell)
[174]
Porcine dermis matrix without any chemical crosslinking Mechanical instability compared to crosslinked meshes. Demonstrated
revascularization, cell repopulation, and cell migration in post-
implantation
XenMatrix
(Brennen
Medical) [175]
Non-crosslinked porcine dermal matrix Facilitates tissue ingrowth and remodeling. Minimizes encapsulation
and ﬁbrotic tissue formation. Available in very large sizes and does not
require tissue reconstitution.
Meshes Derived from Acellular Porcine Liver Tissue
Miromesh
(Miromatrix
Medical) [176]
Non-crosslinked porcine liver matrix Facilitates tissue ingrowth and remodeling, including vascularization.
Minimizes ﬁbrotic tissue formation. Matrix replicates natural tissue
organization.
Table 8
Common allogenic meshes.
Product Comments
AlloDerm (LifeCell)
[177,178]
Especially useful in the prevention of inﬂammation, encapsulation, and infection for defects being treated in contaminated conditions.
FlexHD (Ethicon) [179] A possible drawback of acellular human dermal matrices is that fact that the material being used has already been functionally used by a donor,
making trauma and other comorbid conditions a possibility.
AlloMax (Davol) [180] Mesh has been shown to promote increased inﬁltration of vascular endothelial growth factor and interleukin 8 compared to other acellular
dermal matrices.
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PTFE surfaces, which become less hydrophobic, were more favor-
able for cell attachment, decreased encapsulation and attenuated
inﬂammatory responses [92]. Udpa et al. determined that poly-
propylene meshes coated with chitosan encourage the ingrowth of
skeletal muscle, which can decrease the risk of mesh erosion.
Moreover, chitosan coated meshes produced minimal inﬂamma-
tory responses due to a lack of neutrophil activation [93]. Finally,
substantial work is currently being done involving the coating of
various drugs within mesh architecture. Brandt and Klinge found
that coating PVDF meshes with hydrocortisone and spironolactone
can protect the prosthesis from a host inﬂammatory response [94].
Garcia et al. are working on developing polymer systems capable of
loading non-steroidal anti-inﬂammatory drugs (NSAIDs) within
polypropylene ﬁlms in order establish devices capable of drug
release into localized tissues [95].8. Design of citrate-based elastomers promising for Hernia
repair
Soft tissue engineering has previously been limited by the
mismatch of the physical, particularly mechanical, properties of
commonly used thermoset materials such as PLA, PLGA and PCL
with the native extracellular matrix (ECM) [96]. This mechanicalmismatch prompts inﬂammation and scar formation, limiting the
integration of the implanted material with the host tissue. While
materials such as these have formed the cornerstone of tissue en-
gineering, a new generation of biomaterial design must take into
consideration the native ECM structure towards improving clinical
outcomes. Inspired by the three-dimensional crosslinked ECM
network, composed of collagen, glycosaminoglycans and elastin,
our group has developed a family of citrate-based elastomers
(CBEs) capable of mimicking the mechanical properties and struc-
tural integrity of ECM [96]. Themechanical properties, functionality
and degradation rate of these elastomers can be readily tuned via
modulation of the crosslinking degree, allowing them to be adapted
for a number of applications including hernia repair.
Citric acid, long known for its role in the Kreb’s cycle, is a natural
metabolic product that is nontoxic, inexpensive and readily avail-
able. The presence of three carboxylic acids and one hydroxyl group
on each citrate molecule imparts multifunctionality to CBEs. Citrate
can readily form ester bonds with diol and polyol monomers via a
simple and cost-effective polycondensation reaction without the
need for catalysts, while the various pendant groups of the citrate
molecule can be partially preserved during the initial reaction for
modiﬁcationwith biomolecules or other functional moieties as well
as used to form a 3D network via post-polymerization crosslinking.
The modiﬁcation potential inherent in CBEs has led to a wide
Table 9
Common composite meshes.
Product name Material Design Function
Ventralight ST
(Bard)
(ventralight
ST þ behavior
of new
composite)
Polypropylene (PP),
Sodium Hyaluronate (HA),
Carboxymethylcellulose (CMC),
Polyethylene glycol(PEG),
Poly glycolic acid (PGA)
Monoﬁlament PP ﬁber. Knitted with PGA ﬁber coated
with HA, CMC, and PEG hydrogel.
Minimize adhesion formation by placing PGA coated side
towards viscera
Composix (Bard)
Dulex (Bard)
PP,
ePTFE (evaluation of adhesion
formation)
Macroporous PP on parietal side
Microporous ePTFE on visceral side3 (evaluation of
adhesion)
Lightweight mesh (which mesh for)
Macroporous PP surface is designed to optimize tissue
ingrowth.
Microporous ePTFE is hydrophobic and intended to resist
tissue adhesions functioning as an antiadhesive barrier.
(evaluation of adhesion)
Vypro II (Ethicon)
(partially
absorbable
meshes)
PP,
Polyglactin 910 (92% glycolide, 8%
lactide)
3.4 mm pore size Multiﬁlament Utilize PP mechanical stability while decreasing mesh weight
by integrating absorbable ﬁlament
UltraPro (Ethicon) PP,
Polyglecaprone 25 (PGA
copolymerized with
polycaprolactone(PCL))
Monoﬁlament PP mesh supplemented with
monoﬁlament polyglecaprone 25 (Monocryl).
Weight ~49.6 g/m2 (Inﬂuence of polyglecaprone)
>3 mm pore size (which mesh for repair)
Provide partially absorbable mesh constructed of
monoﬁlament structure in order to decrease risk of infection
(inﬂuence of polyglecaprone)
Dynamesh IPOM
(FEG
Textiltechnik)
PP,
Polyvinylidene ﬂuoride (PVDF)
(which mesh for)
Monoﬁlament PP on the parietal side (mech
properties of)
Monoﬁlament PVDF on the visceral side(Mech prop
of)
Pore size ranges from 1 to 2 mm (which mesh for
repair)
PVDF is especially effective in minimizing the foreign body
response (which mesh for)
Sufﬁcient incorporation and prevention of adhesions
(prevention of parastomal)
Prevadh
(Covidien)
(adhesion
prevention
after myo)
Porcine Collagen,
Polyethylene glycol,
Glycerol,
Lyophilized collagen
Dual sidedmembrane. Containing nonporous porcine
collagen, polyethylene glycol, and glycerol on visceral
side.
Porous, lyophilized porcine collagen on parietal side.
Prevadh is highly hydrophilic and quickly transforms into
hydrogel post implantation. Effective in decreasing
inﬂammation and minimizing adhesion formation,
Parietex
(Sofradim)
Polyester (PET),
collagen type I,
Polyethylene glycol (PEG),
Glycerol
Double layer mesh with PET on parietal side and
hydrophilic collagen membrane on visceral
PET pore size: 700 mm
The PET parietal side is intended to promote tissue inﬁltration
while the hydrophilic collagen membrane minimizes
adhesion formation.
SurgiWarp (MAST
BioSurgery)
(comparison of
three separate)
PP
70:30 poly(L-lactide-co-D,L-L
lactide) (PLA)
Monoﬁlament PP
Macroporous
Containing a PLA adhesion barrier
PLA, which is intended to minimize adhesion formation, is
more mechanical stable than most other adhesion barriers
used.
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Biomaterial implant design must take into consideration a va-
riety of interactions between host and material including blood/
material interactions and implant induced oxidative stress as well
as surgically introduced infection. Both the intrinsic properties and
incorporated functional groups of CBEs have demonstrated signif-
icant attenuation of these adverse occurrences. The hemacompa-
tibilty of poly(octamethylene citrate) (POC) was demonstrated in
early studies, displaying decreased platelet adhesion versus PLGA
and ePTFE [97]. POC coating of vascular grafts resulted in signiﬁcant
reductions of thrombogenicity and inﬂammation [98,99]. Further
modiﬁcation of POC with heparin resulted in an even greater
reduction of whole blood clot mass and platelet adhesion [100].
These results clearly demonstrate the improved blood/material
interactions of CBEs.
In biomaterial induced inﬂammation, cytokines and chemo-
kines generate reactive oxygen species that impair normal cellular
function via DNA, protein and lipid damage [96]. Poly (diol citrates)
have intrinsic antioxidant properties that can be signiﬁcantly
enhanced through the incorporation of ascorbic acid (a common
antioxidant vitamin) or nitric oxide to form poly(octamethylene
citrate eco- ascorbate) (POCA) and diazeniumdiolated POC (POC-
DA) capable of providing extended antioxidant protection
throughout the course of degradation in the case of the former and
for up to one week in the case of the latter [101,102]. The incor-
poration of these antioxidant moieties can greatly diminish
oxidative stress mediated tissue damage in vivo.Signiﬁcant efforts have been made both clinically and in mate-
rial design to limit post-implantation infections. Citric acid is a
highly germicidal compound, imparting CBEs with intrinsic anti-
microbial potential via the lowering of intracellular and cell
membrane pH and possible metal ion chelation within cell mem-
branes as a result of citrate release during degradation, causing
bacterial cell damage and death [96]. The intrinsic antimicrobial
potential of CBEs can be supplemented by functionalization with
quaternary ammonium salts (QAS) and 10-undecylenic acid (UA),
or incorporation of antibiotics, sodium metaperiodate, or silver
nitrate [103e107]. Previous research has demonstrated the effec-
tiveness of these polymers against common bacteria including
Staphylococcus aureus and Escherichia coli.
The physical and mechanical properties and hydrophilic/hy-
drophobic balance of CBEs can also be readily modiﬁed via diol or
acid selection. Incorporating unsaturatedmonomers such as maleic
acid or alkyne and azide containing diols allows additional cross-
linking through free radical or click reactions respectively
[108e110]. The addition of click chemistry to CBEs results in
increased mechanical strength and an additional route to the
incorporation of functional side groups. Additionally, the mechan-
ical properties of CBEs can also be improved by adding urethane
bonds through incorporation of hexamethylene diisocyanate (HDI)
to form crosslinked urethane doped elastomers (CUPEs) [111,112].
Partially or fully replacing aliphatic diols with water soluble
poly(ethylene glycol) (PEG) imparts CBEs with water solubility,
which in combination with double bond containing monomers
Table 10
Common coated meshes.
Product Materials Design Coating function
Sepramesh (Genzyme)
[83,181]
PP
Coating: HA/CMC
Monoﬁlament PP knitted mesh (6 mm
pore) coated on visceral side with
Sepraﬁlm Adhesion Barrier, consisting
of HA/CMC
HA/CMC has been clinically proven to
limit visceral adhesions
PP layer remains in contact with
parietal tissue to promote inﬁltration
Proceed (Ethicon)
[182,183]
PP, Polydioxanone,
Coating: Oxidized regenerated cellulose
(ORC)
PP encapsulated with polydioxanone
parietal layer.
ORC coated on visceral layer
Mesh is design to promote tissue in
growth on the parietal side and resist
adhesion formation on the ORC coated
side
Physiomesh (Ethicon)
[5,184]
PP, polydioxanone
Coated: Monocryl polyglecaprone 25
Monoﬁlament PP mesh
Coated with Monocryl on the peritoneal
and subcutaneous sides.
Polydioxone ﬁlm binds coating to mesh
Mesh is coated to resist adhesion
formation with visceral tissues and
decrease seroma development
TiMesh (PFM Medical)
[33,185]
PP
Coating: plasma activated chemical
vapor deposition of atomic Titanium
Monoﬁlament PP
Coated with 30 mm Titanium layer
Available in: 16 g/m2, 35 g/m2, 65 g/m2
all with pore sizes >1 mm
The titanium coating increases the
mesh hydrophilicity, which enhances
contact with soft tissues
TiO2 (BioCer)
[185]
PP
Coating: Titanium Dioxide
Monoﬁlament PP
Pore Size: 3.0 mm
Weight: 45 g/m2
PP ﬁlament are coated with titanium
dioxide
Titanium coating allows for less post-
operative pain, lower analgesic
consumption, and quicker return to
everyday movement
Glucamesh (Genzyme)
[186,187]
PP
Coating: beta-D-glucan
Microporous PP
Weight: 55 g/m2
3% beta-glucan coating
Beta-glucans extracted from oats have
been shown to be effective promotors
of wound healing and tissue integration
C-Qur (Atrium)
[35,188]
PP
Coating: Omega 3 fatty acid
Monoﬁlament PP Weight: 50 g/m2
Pore size: >1 mm
The use of omega 3 fatty acid complexes
as coatings on meshes has shown a
decrease in adhesion formation as well
as an attenuated inﬂammatory
response
Zenapro (Cook Medical) [189] PP
Coating: porcine SIS
Lightweight macroporous PP coated
with 8 ply porcine SIS
The biologic SIS coating may shield the
synthetic PP from infection while
allowing eventual replacement with
native tissue, incorporating the
synthetic component into the
surrounding tissue. Could be used to
diminish the risk of ﬁstulization and
infection.
S. Kalaba et al. / Bioactive Materials 1 (2016) 2e1712facilitates in situ crosslinking. In situ crosslinkable CBE formulations
including poly((ethylene glycol) maleate citrate) (PEGMC) have
been utilized as void ﬁlling materials as well as potential drug or
cell delivery systems [113e117].
The introduction of dopamine, a catechol containing biomole-
cule similar to the catechol containing amino acid DOPA that im-
parts mussels with excellent wet surface adhesion, to PEG
containing CBEs resulted in the development of injectable citrate-
based mussel-inspired bioadhesives (iCMBAs). iCMBAs display a
wet tissue adhesion strength 2.5e8.0 times stronger than gold
standard ﬁbrin glue and their hydrolytically liable ester bonds
make them completely biodegradable [118]. The incorporation of
antifungal 10-undecylenic acid into the polymer and sodium peri-
odate or silver nitrate mediated free radical crosslinking imparts
iCMBAs with antimicrobial properties [109]. This combined with
the ability to deliver water soluble drugs or biomolecules makes
iCMBAs an attractive alternative to clinically utilized adhesives for
suture less wound closure post-surgery.
Biodegradable ﬂuorescent materials have been a major research
focus for theranostic healthcare and in vivo imaging [96]. Previous
efforts have focused on the incorporation of organic dyes or
quantum dots through encapsulation or conjugation; however,
these systems suffer from theminimal photobleaching resistance of
organic dyes and the potential toxicity of quantum dots. The
incorporation of essential amino acids into CBEs imparts ﬂuores-
cence, resulting in the synthesis of biodegradable photo-
luminescent polymers (BPLPs). In contrast to previous aromatic
ﬂuorescent polymers or organic dyes, BPLPs remain fully biode-
gradable and display elastic properties [119,120]. BPLPs display
quantum yields of up to 62.3%, low photobleaching and tunableﬂuorescence depending on amino acid selection [121,122]. BPLPs
are also capable of initiating ring opening polymerization of lactone
monomers, resulting in the development of biodegradable photo-
luminescent polylactide (BPLP-PLA) [123]. BPLP-PLAs display
tunable and strong ﬂuorescence, with quantum yields of up to 51%
[123]. Incorporation of BPLPs and BPLP-PLA into tissue engineering
systems allows for non-invasive in vivo imaging as well as degra-
dation tracking.
Given the advantages of CBEs in tunable elastomeric mechanical
properties, hemacompatibility, biocompatibility, antimicrobial and
antioxidative potential as well as the above demonstrated degree of
potential functionality, the incorporation of CBE coatings to hernia
meshes is expected to result in improved clinical outcomes. As a
demonstration of the ability to coat meshes with CBEs, BPLP was
coated on non-degradable PP meshes, resulting in an even coating
that can improve tissue/material interactions (Fig. 2). Incorporation
of BPLP also adds potential imaging in vivo and with the incorpo-
ration of drugs or growth factors could actively aid in the regen-
eration process. Additional coatings of CBEs such as POC, POCA, or
antimicrobial UA and silver containing elastomers could impart the
favorable properties of these biodegradable materials to existing or
developed hernia meshes. The development of CBEs expands the
repertoire of available biomaterials as coatings and adhesives for
non-degradable hernia meshes or even in the fabrication of fully
degradable scaffolds for hernia repair and regeneration.
9. Future perspectives for hernia repair
To date, signiﬁcant progress has been achieved in the design of
materials for hernia repair; however, as outlined above, multiple
Fig. 2. Poylpropylene (PP) hernia mesh before (A) and after (B) coating with BPLP. Cross sections of PP hernia mesh before (C) and after (D) coating with BPLP.
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the acute and chronic foreign body response to the implanted
material, preventing/controlling post-operative infection, promot-
ing tissue ingrowth and vascularization, and achieving physiolog-
ically relevant mechanical properties.
In recent years, biomaterials research has undergone a paradigm
shift from creating largely passive scaffolds, designed to provide
mechanical and structural stability while having minimal positive
effect on tissue growth, to “active” materials, capable of inﬂuencing
and directing tissue regeneration via the incorporation of drugs,
cells, or materials with favorable intrinsic properties within the
scaffold. Additionally, with the advent of additive manufacturing
and other fabrication techniques, there is signiﬁcant drive toward
the generation of custom, patient speciﬁc implants.
Despite these trends, hernia repair remains largely dependent
on non-degradable materials designed as one size ﬁts all patches
with minimal to no ability to actively encourage tissue regenera-
tion. Future research will focus on the incorporation of new tech-
nologies and of new materials toward solving these remaining
challenges and improving patient outcomes.
9.1. Absorbable surface coatings and meshes
The use of non-absorbable implant materials has long been
associated with signiﬁcant instances of chronic inﬂammation and
foreign body response leading to impaired tissue regeneration and
in extreme cases the necessity for surgical removal of the implant.The permanent presence of a foreign material will also typically
lead to ﬁbrous and scar tissue formation, resulting in a non-
physiological replacement tissue whose mechanical and physical
properties do not match those desired. Additionally, the mismatch
of mechanical properties of most non-degradable mesh materials
can combine with scar tissue to create areas of discomfort and
limited mobility. Consequently, a major focus of biomaterials
research is the replacement of permanent or semi-permanent im-
plants, such as metals and non-absorbable plastics, with fully
degradable counterparts.
Currently, non-absorbablematerials aremost common in hernia
repair; however, several absorbable materials, based upon syn-
thetic polymers including PLA and PGA or bio-derived materials,
such as chitosan, collagen and dermal extracellular matrix (ECM)
are currently being tested [124e126]. These materials allow com-
plete replacement with mature neo-tissue and in the case of bio-
derived materials signiﬁcantly improve tissue ingrowth and
foreign body response. However, fully absorbable implants are
often limited by insufﬁcient mechanical properties, prompting
research into absorbable coatings on clinically utilized meshes
designed to improve the tissue/implant interface as well as incor-
porate drugs and growth factors [127e129]. Polypropylene meshes
have been coated with materials including Poly(ethylene glycol)
(PEG), chitosan, and porcine extracellular matrix [127e129].
Among these coatings, ECM is the most promising, with ECM
coated heavy-weight meshes displaying a foreign body response
and tissue remodeling resembling a light-weight mesh [127,130].
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capable of improving mesh biocompatibility while also allowing
drug and growth factor incorporation andwill thus be amajor focus
in the future, while the development of more mechanically robust
materials will also remain a major focus toward creating viable,
fully absorbable meshes.
9.2. Drug eluting meshes
The presence of post-operative infection is a major concern in
hernia repair, preventing wound healing and necessitating addi-
tional surgeries. Currently, reported rates of mesh infection are as
high as 10% [131,132]. These rates vary widely based on mesh type,
technique, location of the mesh, and wound class (clean, clean/
contaminated, contaminated, and dirty/infected). The occurrence
of infection in laparoscopic placement is typically much lower than
in open placement procedures, while microporous, multiﬁlament,
heavy-weight meshes suffer from a higher rate of infection than
their low-weight, monoﬁlament counterparts [13,133,134]. The
ability to deliver drugs locally from implants, reducing the off-
target effects and drug degradation/elimination inherent in sys-
temic delivery, will improve the effectiveness of treating potential
infection. Many surgeons presoak synthetic mesh in antibiotic so-
lution prior to implantation. Sadava et al. looked at the presence of
bioﬁlm on 4 different types of mesh (composite multiﬁlament
polyester, multiﬁlament polyester, composite monoﬁlament poly-
propylene, and monoﬁlament polypropylene) that were either
soaked in saline or a vancomycin solution after 30 days of im-
plantation in a rat model [135]. They found that meshes soaked in
vancomycin prior to implantation had a much higher rate of
clearance in all types of mesh examined. Yurko et al. bound various
antimicrobial peptides (Lysozyme, human beta defensin, human
cathelicidin, and lysostaphin) to polypropylene mesh and
measured the antimicrobial action in a suspension of s. aureus
[136]. They found that mesh impregnated with lysostaphin had
superior antimicrobial activity. Gore Dualmesh Plus Biomaterial
(WL Gore & Associates, Flagstaff, AZ) is an ePTFE mesh that is
coated with silver carbonate and chlorhexidine diacetate. In one
study comparing bacterial adherence on Dualmesh Plus with
numerous other commercially available meshes, the Dualmesh Plus
was the onlymesh that had no identiﬁable bacteria after a one hour
incubation period in a bacterial bath [137]. Additionally, biode-
gradable meshes and mesh coatings incorporating silver as well as
antibiotic drugs including ciproﬂoxacin, ampicillin, and vancomy-
cin have shown effectiveness over extended time periods in the
inhibition of infection in vitro and in vivo [128,129,138e140].
The incorporation of growth factors to improve tissue regener-
ation is also of critical importance given the inability or limited
ability of most materials used in hernia repair (with the exception
of ECM) to promote tissue growth. Incorporation of bFGF in a
collagen scaffold and bFGF, TGF-B and IGF-1 in a PCL ﬁber coated PP
mesh resulted in accelerated collagen and myoﬁbril integration as
well as increased mechanical strength in the case of the former and
increasedmechanical strength due to tissue growth and integration
in the case of the latter [125,141]. From these studies, it is clear that
incorporation of drugs and growth factors to improve tissue
regeneration and prevent infection will be critical to improving
hernia repair.
9.3. Stem cell pre-seeding and encapsulation
Although adequate, acellular implants often take signiﬁcant
time to cellularize, increasing healing time. Pre-seeding of scaffolds
with stem cells, particularly autologous populations, has the po-
tential to accelerate the healing process. Seeding of mesenchymalstem cells within both synthetic Ultrapro, Vicryl and Marlex
meshes as well as dermal ECM scaffolds resulted in a viable cell
population capable of implantation [142,143]. ECM scaffolds in
particular displayed angiogenesis, complete defect repair, and
improved mechanical properties over their acellular counterparts
in vivo [142]. In the future, absorbable coatings or scaffolds could be
used to encapsulate stem cells prior to implantation. Such meshes,
alone or combined with local delivery of encapsulated growth
factors, could signiﬁcantly decrease healing time.
9.4. Custom and anisotropic meshes fabricated with additive
manufacturing
Current hernia meshes are typically one dimensional and have
limited customizability for speciﬁc wound requirements. Addi-
tionally, current meshes display isotropic mechanical and physical
properties that fail to replicate the anisotropic nature of the
abdominal musculature and the forces generated in the abdominal
area. Meshes capable of better replicating the wound area and
mechanical environment could potentially reduce implant failure
and improve integration and healing.
Anisotropic mechanical and swelling properties have previously
been achieved utilizing electrospinning with multiple ﬁber align-
ments as well as 3D printing of materials with anisotropic swelling
characteristics to create controlled mechanics and complex 3D
shapes [144,145]. Additive manufacturing techniques such as 3D
printing are capable of fabricating mesh structures as well as plugs
and other 3 dimensional constructs that could conform to the in-
dividual patient. 3D printing is also capable of incorporating mul-
tiple materials and porosities into a single scaffold in a highly
controlled manner. Utilizing 3D printing, scaffolds can be designed
with varying pore structures, ﬁber orientations, and material
properties, imparting mechanical anisotropy. Integrating computer
modeling and diagnostic imaging, custom implants could be
generated that conform to the patients’ speciﬁc anatomical
requirements.
In the future, hernia repair will incorporate not only scaffolding
but active elements such as drugs, growth factors, and cells capable
of improving and accelerating the healing process. Novel materials
will lead to improved host response andmaterial integration, while
improved manufacturing will result in custom implants capable of
better mimicking the native tissue in terms of mechanics. Non-
degradable mesh implants will be replaced by partially or fully
absorbable scaffolds capable of attenuating foreign body response
and infection while promoting tissue ingrowth and maturation,
leading to improved patient outcomes.
10. Conclusion
The importance of the surgical repair of hernias has been
recognized since the 19th century. From the earliest surgical tech-
niques, utilizing metal sutures, hernia repair has evolved to include
a variety of surgical strategies and mesh implants. Despite the
availability of multiple products clinically, implants continue to
suffer frommultiple limitations, and there is no ideal mesh capable
of preventing adverse effects. Multiple design characteristics,
including material, pore size, ﬁlament structure and mesh weight
are critical to the success of the implant. Non-absorbable meshes,
composed of materials such as polypropylene and ePTFE, display
improved host response compared to the earlier metal implants;
however, they still suffer from adhesions, mechanical mismatch
and potential scar tissue formation. Absorbable materials, whether
synthetic, such as polycaprolactone, or bio-derived, elicit even
more favorable immune responses and are replaced by natural
tissue over time. Combination meshes, composed of both non-
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multiple materials and morphologies to minimize adhesions, in-
fections and other complications, while coated implants provide
the opportunity for local delivery of growth factors and drugs.
As discussed above, the choice of material is critical to success in
hernia repair, necessitating the development of novel materials or
coatings. Ideally, fully biodegradable hernia meshes possessing
improved host interactions will become commonplace in the
future; however, this requires the development of new materials
capable of maintaining the required mechanical strength during
degradation and promoting tissue ingrowth. Alternatively, the use
of biodegradable coatings comprising citrate based elastomers or
other biocompatible polymers should be further investigated to
improve outcomes where non-absorbable meshes are used. These
coatings could also be used as wells for drugs, growth factors, or
other active molecules as well as enabling imaging. Despite a long
history of advancement, signiﬁcant challenges remain, and the
development of novel materials and designs remains critical to
improving patient outcomes in the future.
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